Clevidipine
Back to searchMolecule Structure
Scientific Name
Clevidipine
Description of the Drug
Clevidipine is a dihydropyridine L-type calcium channel blocker used to lower blood pressure when oral antihypertensive therapy is not feasible or not desirable.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04920
http://www.drugbank.ca/drugs/DB04920
Brand Name(s)
Cleviprex
Company Owner(s)
Chiesi Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Voltage-gated L-type calcium channel | PROTEIN FAMILY | BLOCKER | CHEMBL2095229 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL115522 | ||
| Human Metabolome Database | HMDB0250321 | ||
| DrugBank | DB04920 | ||
| PubChem: Thomson Pharma | 14857919 | ||
| PubChem | 153994 | ||
| Mcule | MCULE-6863602192 | ||
| Nikkaji | J772.200A | ||
| BindingDB | 50088387 | ||
| EPA CompTox Dashboard | DTXSID6057661 | ||
| DrugCentral | 674 | ||
| ChemicalBook | CB01118391 | ||
| Guide to Pharmacology | 7468 | ||
| rxnorm | CLEVIDIPINE BUTYRATE | CLEVIPREX | CLEVIDIPINE |
| PubChem: Drugs of the Future | 12015001 | ||
| ChEBI | 135738 |
